In ERIN we aim for close cooperation and sharing the existing scientific and clinical excellence among the partners to address and overcome two major challenges in reproductive medicine innovations, bringing thereby remarkable change to involved institutions, to the research field, and to society at large. The two challenges are:
By tackling these challenges, the consortium aims to enhance the ethical preparedness of the consortium partners and bring more ethically responsible innovations into clinic that do not harm the interests of the various stakeholders, are evidence-based and cost-effective and therefore could be implemented in a sustainable way to ensure that these novel solutions become widely and equally accessible to as many patients as possible.
Programme: H2020-EU.4.b. – Twinning of research institutions
Topic: WIDESPREAD-05-2020 – Twinning
Call for proposal: H2020-WIDESPREAD-2020-5
Funding scheme: CSA – Coordination and support action
Project title: Ethically Responsible INnovations in reproductive medicine
Acronym: ERIN
Project number: 952516
Funding period: 01.09.2020. – 31.12.2023.
Total funding: € 899 625